Dixon Hubard Feinour & Brown Inc. VA Has $2.57 Million Stake in ICU Medical, Inc. (ICUI)

Dixon Hubard Feinour & Brown Inc. VA raised its position in ICU Medical, Inc. (NASDAQ:ICUI) by 300.5% during the second quarter, Holdings Channel reports. The firm owned 14,920 shares of the medical instruments supplier’s stock after buying an additional 11,195 shares during the period. Dixon Hubard Feinour & Brown Inc. VA’s holdings in ICU Medical were worth $2,574,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. State of Alaska Department of Revenue boosted its stake in ICU Medical by 81.0% in the second quarter. State of Alaska Department of Revenue now owns 2,969 shares of the medical instruments supplier’s stock worth $512,000 after buying an additional 1,329 shares during the last quarter. Fisher Asset Management LLC boosted its stake in ICU Medical by 103.2% in the second quarter. Fisher Asset Management LLC now owns 63,000 shares of the medical instruments supplier’s stock worth $10,868,000 after buying an additional 32,000 shares during the last quarter. GW&K Investment Management LLC boosted its stake in ICU Medical by 2.7% in the second quarter. GW&K Investment Management LLC now owns 495,697 shares of the medical instruments supplier’s stock worth $85,508,000 after buying an additional 12,808 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in ICU Medical by 17.1% in the first quarter. Goldman Sachs Group Inc. now owns 374,203 shares of the medical instruments supplier’s stock worth $57,141,000 after buying an additional 54,756 shares during the last quarter. Finally, Janus Capital Management LLC boosted its stake in ICU Medical by 178.8% in the first quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock worth $219,864,000 after buying an additional 923,395 shares during the last quarter. Institutional investors and hedge funds own 77.90% of the company’s stock.

ICU Medical, Inc. (NASDAQ:ICUI) traded up 0.17% on Monday, reaching $173.25. 100,379 shares of the company’s stock traded hands. ICU Medical, Inc. has a 12-month low of $108.51 and a 12-month high of $176.50. The stock has a 50 day moving average price of $166.30 and a 200 day moving average price of $152.58. The stock has a market cap of $3.43 billion, a price-to-earnings ratio of 30.79 and a beta of 0.37.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, May 10th. The medical instruments supplier reported $1.68 EPS for the quarter, beating the consensus estimate of $0.45 by $1.23. The business had revenue of $247.74 million for the quarter, compared to the consensus estimate of $237.12 million. ICU Medical had a net margin of 18.76% and a return on equity of 9.63%. The business’s revenue for the quarter was up 175.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.26 EPS. Analysts forecast that ICU Medical, Inc. will post $4.14 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This story was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.com-unik.info/2017/07/17/dixon-hubard-feinour-brown-inc-va-has-2-57-million-stake-in-icu-medical-inc-icui.html.

A number of equities research analysts have recently commented on the stock. Zacks Investment Research cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Friday. BidaskClub cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Sidoti cut shares of ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. Finally, Roth Capital cut shares of ICU Medical from a “buy” rating to a “neutral” rating in a report on Thursday, May 11th. They noted that the move was a valuation call. Five research analysts have rated the stock with a hold rating, ICU Medical presently has an average rating of “Hold” and a consensus target price of $157.00.

In other news, Chairman Vivek Jain sold 100,000 shares of the company’s stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $170.80, for a total value of $17,080,000.00. Following the sale, the chairman now directly owns 110,925 shares of the company’s stock, valued at approximately $18,945,990. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Joseph R. Saucedo sold 4,500 shares of the company’s stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $162.51, for a total transaction of $731,295.00. Following the completion of the sale, the director now directly owns 3,091 shares in the company, valued at $502,318.41. The disclosure for this sale can be found here. Insiders sold a total of 222,872 shares of company stock worth $37,839,895 over the last ninety days. Insiders own 15.90% of the company’s stock.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

What are top analysts saying about ICU Medical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ICU Medical Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit